サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1467249

生物学的安全キャビネットの世界市場

Biological Safety Cabinets
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
生物学的安全キャビネットの世界市場
出版日: 2024年04月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

生物学的安全キャビネットの世界市場は2030年までに3億1,880万米ドルに達する

2023年に2億1,360万米ドルと推定された生物学的安全キャビネットの世界市場は、2023年から2030年にかけてCAGR5.1%で成長し、2030年には3億1,880万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるクラスIの生物学的安全キャビネットは、CAGR5%を記録し、分析期間終了時には1億1,100万米ドルに達すると予測されます。クラスIIの生物学的安全キャビネットセグメントの成長は、今後8年間のCAGRが5.6％と予測されています。

米国市場は6,330万米ドル、中国はCAGR4.8％で成長予測

米国の生物学的安全キャビネット市場は、2023年には6,330万米ドルになると推定されます。世界第2位の経済大国である中国は、2023年から2030年までの分析期間においてCAGR4.8%で推移し、2030年までに5,580万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、それぞれ2023年から2030年にかけて4.6%と4.2%の成長が予測されています。欧州では、ドイツがCAGR約3.9%で成長すると予測されています。

2024年に向けたエキサイティングな新レポート機能のご紹介

インフルエンサーのエンゲージメント統計へのフルアクセス

デジタルアーカイブと「MarketGlass」調査プラットフォームへの無料アクセスがあります。当社独自のMarketGlassプラットフォームは、世界中の専門家の創造性と市場知識を統合的かつ協調的に解き放つことができます。当社の最先端のツールは、市場参入企業のプライバシーとアイデンティティを保護しながら、世界クラスの市場展望をもたらします。レポート内の数字、統計、市場に関する説明は、この分野の専門家や影響力のある人々によって共有された、完全に厳選された洞察に基づいています。

リアルタイムのデータシミュレーター・ツールや特注のレポート作成機能を備えたインタラクティブなアンケートへの参加機会

企業間のスマートな意見交換のためのピアコラボレーティブ・インタラクティブプラットフォームへのフルクライアントアクセス

1年間の無料レポート更新

主要プレーヤーの世界市場シェアを含む競合カバレッジ

複数の地域にまたがるプレーヤーの市場プレゼンス分析（好調/活発/ニッチ/マイナー）

専門家/インフルエンサーのインタビュー、ポッドキャスト、報道発表、イベント基調講演のYouTubeビデオへのアクセス

2024年の世界経済に期待すること

金融引き締めとそれに伴う金利上昇によって引き起こされる地政学的、経済的不安定性が、2024年の激動の情勢を作り出すと思われます。中東での敵対行為や、ますます頻発する気候災害など、いくつかの要因が回復への道筋に圧力をかけ続けると思われます。リスクの一方で、ディスインフレの兆候が強まり、頑迷なインフレに対する不安が緩和され、サプライチェーンが正常化し、エネルギーコストの変動にもかかわらず物価が緩やかになるなど、いくつかのプラス材料も具体化しつつあります。インドや米国をはじめとするG21諸国の選挙は、資本の流れや投資戦略に影響を与える可能性があります。インドが世界的な投資先として注目される一方で、米国を拠点とするハイテク企業は、才能と資本のダイナミックなエコシステムに後押しされ、引き続き優位を保つと思われます。シリコンバレーをはじめとする技術的機会は、国内経済が減速しているとはいえ底堅く、規制環境も整備されていることから、高成長の可能性を求める投資家にとって引き続き魅力的です。欧州は金融引き締め政策と景気後退リスクとの戦いが続きますが、英国は見通しが最も厳しく、2024年の景気後退リスクが最も高いです。中国は、政府支出と個人消費の改善に支えられた成長が期待されるもの、引き続き不確定要素となります。不安定な環境は、投資家にも企業にもチャンスと課題の両方をもたらすと思われます。成長への触媒としてボラティリティを受け入れるとともに、敏捷性と戦略的な先見性をもって投資判断に臨むことが、生き残りのために重要であることに変わりはありません。

調査対象企業の例

  • Air Science LLC
  • Berner International
  • BIOBASE
  • Cruma-Diantech Solutions S.L.
  • Esco Micro Pte. Ltd.
  • Euroclone S.p.A.
  • Germfree
  • Kewaunee Scientific Corporation
  • Labconco Corporaton
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP10718

Global Biological Safety Cabinets Market to Reach $318.8 Million by 2030

The global market for Biological Safety Cabinets estimated at US$213.6 Million in the year 2023, is expected to reach US$318.8 Million by 2030, growing at a CAGR of 5.1% over the period 2023-2030. Class I Biological Safety Cabinets, one of the segments analyzed in the report, is expected to record 5% CAGR and reach US$111 Million by the end of the analysis period. Growth in the Class II Biological Safety Cabinets segment is estimated at 5.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $63.3 Million, While China is Forecast to Grow at 4.8% CAGR

The Biological Safety Cabinets market in the U.S. is estimated at US$63.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$55.8 Million by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -

  • Air Science LLC
  • Berner International
  • BIOBASE
  • Cruma - Diantech Solutions S.L.
  • Esco Micro Pte. Ltd.
  • Euroclone S.p.A.
  • Germfree
  • Kewaunee Scientific Corporation
  • Labconco Corporaton
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biological Safety Cabinet to Register Steady Growth
    • Class II Biological Safety Cabinets to Account for Highest Growth, Driven by Higher Level of Protection
    • A Brief Description of Class I, Class II, and Class III Biological Safety Cabinets
    • By End-User Segment, Pharmaceutical & Biopharmaceutical Companies to Register Largest Growth
    • Market Share of Biological Safety Cabinet by End-User Type
    • Biological Safety Cabinets - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Emergence of Various Communicable Diseases to Bode Well for Market Demand
    • Breakdown of Total Number of Diseases Reported by Disease Variety: 1980 to 2010
    • Total Number of Disease Cases from Fleas, Ticks, and Mosquitoes in the US: 2004 to 2016
    • Innovations to Support Market Growth
    • Spur in R&D Activities to Bode Well for Market Growth
    • Total Worldwide Spending (in Billion USD) on Pharmaceutical R&D: 2010 to 2024
    • Availability of Alternatives to Biological Safety Cabinets to Deter Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biological Safety Cabinets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biological Safety Cabinets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biological Safety Cabinets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Class I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Class I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Class I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Class II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Class II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Class II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Class III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Class III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Class III by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic & Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic & Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic & Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic & Research Institution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Academic & Research Institution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Biological Safety Cabinets Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • JAPAN
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • CHINA
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • EUROPE
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Biological Safety Cabinets by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Biological Safety Cabinets by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • FRANCE
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • GERMANY
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030

IV. COMPETITION